Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06269055 · ClinicalTrials.gov registry record
Long-term Result of DTPA (Diethylenetriamine Pentaacetate) Chelation for Gadolinium Deposition Disease
A clinical trial of Gadolinium Deposition Disease and Ca-DTPA, sponsored by Stanford University.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06269055 is a study of Gadolinium Deposition Disease and Ca-DTPA that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06269055, a study of Gadolinium Deposition Disease and Ca-DTPA, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is aimed at describing the degree of benefit, if any, and the adverse effects, if any, from receiving 5 or more treatment sessions of Gadolinium Deposition Disease using two-day chelation treatment with the chelating agents Calcium Diethylenetriamine pentaacetate (Ca-DTPA) and Zinc Diethylenetriamine pentaacetate (Zn-DTPA).
Conditions Studied
Interventions
- OTHER Interview
Study Locations (1)
California
- Stanford University Medical Center - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-12-02 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06269055
The ClinicalTrials.gov registry entry for NCT06269055 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gadolinium Deposition Disease appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT06269055 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06269055 about?
NCT06269055 is a clinical study titled "Long-term Result of DTPA (Diethylenetriamine Pentaacetate) Chelation for Gadolinium Deposition Disease". This study is aimed at describing the degree of benefit, if any, and the adverse effects, if any, from receiving 5 or more treatment sessions of Gadolinium Deposition Disease using two-day chelation treatment with the chelating agents Calcium Diethylenetriamine pentaacetate (Ca-DTPA) and Zinc Diethy...
What is the current status of trial NCT06269055?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-12-02. Estimated completion is 2026-05.
What conditions does trial NCT06269055 study?
This clinical trial studies the following conditions: Gadolinium Deposition Disease, Ca-DTPA.
What interventions are being tested in trial NCT06269055?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT06269055?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06269055 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.